Colorectal Cancer Canada

1350 Sherbrooke West, Suite 300
Montreal, QC H3G 1J1
President & CEO: Barry D. Stein
Executive Director: Carole Brohman

Charitable Reg. #:86657 2423 RR0001

STAR RATING

Ci's Star Rating is calculated based on the following independent metrics:

[Charity Rating: 4/5]

✔+

FINANCIAL TRANSPARENCY

Audited financial statements for current and previous years available on the charity’s website.

A-

RESULTS REPORTING

Grade based on the charity's public reporting of the work it does and the results it achieves.

n/r

DEMONSTRATED IMPACT

The demonstrated impact per dollar Ci calculates from available program information.

NEED FOR FUNDING

Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.

80%

CENTS TO THE CAUSE

For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 80 cents are available for programs.



My anchor

OVERVIEW

About Colorectal Cancer Canada:

Colorectal Cancer Canada is a 4-star charity with low overheads costs, one of the best in the Canadian health charity sector. It is financially transparent and has an above-average results reporting score.

Founded in 2017, Colorectal Cancer Canada (CCC) supports adults living with colorectal cancer. The charity is the product of the merger of the Colorectal Cancer Association of Canada and Colon Cancer Canada. CCC reports that in 2022 colorectal cancer was the fourth most diagnosed cancer in Canada, affecting 24,300 Canadians each year.

Colorectal Cancer Canada's main programs are Education and Awareness, Patient Support and Advocacy. It publishes educational materials to raise awareness of early-onset symptoms and treatment options.

Education and Awareness accounted for 54% of the charity's program spending. CCC provides patient resources through its website and social media accounts. In F2022, its website had 73,200 unique visitors (64,320 in F2021). The Never Too Young (N2Y) program raises awareness of early-onset colorectal cancer. In F2022, CCC launched an Early Age Onset Support Group catered to young cancer patients around Canada. The charity also published the new N2Y Toolkit, a digital resource to help young cancer patients. The Immunotherapy Awareness program aims to raise awareness about immunotherapy as a cancer treatment. In F2022 CCC released a patient and caregiver guide to immunotherapy.

Patient Support represented 28% of program spending. CCC has four dedicated patient support groups. It also offers personalized support to patients and caregivers. The charity reports that 188 patients and caregivers received personalized support in F2022. In the same fiscal year, CCC launched a new program called Cope Thrive Survive. It aims to help cancer patients, survivors and caregivers get back to everyday life.

Advocacy and Policy is CCC's third program, accounting for 18% of program spending. The charity organized one clinical research trial conference in F2022. The conference attendees included researchers, patients, and industry agencies. CCC also gathered and submitted patient group input on the cancer drug Entrectinib, which is under consideration by the Canadian Agency for Drugs and Technologies in Health.

My anchor

Results and Impact

In F2022, Colorectal Cancer Canada’s newsletter had 23,600 active subscribers (16,000 in F2021). The charity reports that the newsletter has a 41% read rate.

In F2022 CCC also organized the Colorectal Cancer Community Conference. It hosted 9 individual conference sessions and 33 speakers, and there were 200 registered attendees. Of those surveyed, 92% said that they were extremely or very satisfied with their experience.

While Ci highlights these key results, they may not be a complete representation of Colorectal Cancer Canada's results and impact.

This charity is not yet rated on impact (n/r).

My anchor

Finances

Colorectal Cancer Canada received $1.7m in donations and special events revenue in F2022. Administrative costs are 11% of revenues, and fundraising costs are 9% of donations in F2022, down from 45% in F2020. This means that CCC spent 20% on overhead in F2022 compared to 61% in F2020. The charity does not report why these costs dropped so significantly. In F2022, for every dollar donated, 80 cents go to the cause. Total overhead spending falls within Ci's reasonable range for this fiscal financial year. IT was within the range also in F2021; however, it was outside of the range the three years prior to that.  

CCC has $1.3m in reserve funds. These are the charity’s cash and investments. With current reserves, CCC can cover 11 months of annual program costs.  

In addition to reported salary information, CCC paid consulting fees to a director of approximately $280k in F2022 ($254k in F2021 and F2020). Compensation figures for staff do not include these consulting fees. CCC's audited financial statements do not disclose activity-based costing. Charity Intelligence reports the breakdown of CCC's program, fundraising, and administrative costs from CCC's T3010 filing.

This charity report is an update that has been sent to Colorectal Cancer Canada for review. Changes and edits may be forthcoming.

Updated June 13, 2023 by Alessandra Castino.

Financial Review


Financial Ratios

Fiscal year ending June
202220212020
Administrative costs as % of revenues 11.2%8.2%16.2%
Fundraising costs as % of donations 8.8%3.2%44.5%
Total overhead spending 20.0%11.4%60.7%
Program cost coverage (%) 91.6%104.9%80.9%

Summary Financial Statements

All figures in $s
202220212020
Donations 1,310,6301,478,024467,332
Government funding 52,183172,18289,588
Special events 378,71166,097730,697
Investment income 6,5514,9236,526
Other income (1,761)(4,115)13,790
Total revenues 1,746,3141,717,1111,307,933
Program costs 1,378,9031,108,7051,012,391
Administrative costs 195,185140,501210,836
Fundraising costs 148,08948,644533,459
Total spending 1,722,1761,297,8511,756,686
Cash flow from operations 24,138419,260(448,753)
Capital spending 2,30910,52832,663
Funding reserves 1,262,8891,162,523818,699

Note: Ci adjusted for deferred contributions affecting donations by ($21k) in F2022, $296k in F2021, and ($442k) in F2020. Ci took program, administrative, and fundraising costs from the charity's T3010 filings with the CRA for all three years. Amortization expense was removed from program, administrative and fundraising costs on a pro rata basis. Ci reported government funding from the charity's T3010 filing with the CRA and removed the revenue from donations. Ci reported the Canada Emergency Rent Subsidy and Canada Emergency Wages Subsidy programs as revenue under government funding and added it pro-rata to program, administrative and fundraising costs, affecting revenue and expenses by $47k in F2022 and $147k in F2021.

Salary Information

Full-time staff: 7

Avg. compensation: $66,836

Top 10 staff salary range:

$350k +
0
$300k - $350k
0
$250k - $300k
0
$200k - $250k
0
$160k - $200k
0
$120k - $160k
0
$80k - $120k
2
$40k - $80k
5
< $40k
0

Information from most recent CRA Charities Directorate filings for F2022

My anchor

Comments & Contact

Comments added by the Charity:

Charity Contact

Website: www.colorectalcancercanada.com
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 1-877-502-6566

Print